Market revenue in 2023 | USD 83.8 million |
Market revenue in 2030 | USD 126.7 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.83% in 2023. Horizon Databook has segmented the South Africa intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa is a middle-income economy and has a very high prevalence of HIV/AIDS, which has infected about 5.7 million people in the country at a prevalence of 12%. The other chronic diseases that are commonly diagnosed in the country are cancer and diabetes, which accounted for 28% of all deaths in 2018.
According to the Global Health Report, by 2030, 23.6 million South African adults will suffer from diabetes, which will be more than the number of people currently suffering from HIV, along with a rise in multimorbidity. The application of medical technology and improved public health, including better access to healthcare, is a major focus of the country.
The South African Medical Device Industry Association (SAMED) oversees all reimbursements for medical devices, including infusion pumps, pacemakers, and diagnostic equipment. It also promotes innovation in medical technology.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into South Africa intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account